Joel Lewis
President and CEO · GALECTIN THERAPEUTICS INC
- 2024
- Jan 22, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joel Lewis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 10X Fund, L.P. - $2.19M in GALT purchases and sales in the last 12 months
- Khurram Jamil - $1.44M in GALT purchases and sales in the last 12 months
- Jack W. Callicutt - $944K in GALT purchases and sales in the last 12 months
- Harold H. Shlevin - $501K in GALT purchases and sales in the last 12 months
- Kevin D. Freeman - $20K in GALT purchases and sales in the last 12 months
- Kary Eldred - $3K in GALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joel Lewis?
Joel Lewis is a corporate insider, tracked as President and CEO of GALECTIN THERAPEUTICS INC (GALT). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joel Lewis last file a Form 4?
The most recent primary Form 4 on record is dated 22 January 2026, one of 11 filings going back to 2024.
Has Joel Lewis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($759K) across all tracked filings.
